Impax Shareholders

SAN FRANCISCO - A federal judge dismissed with leave to amend a shareholders derivative complaint accusing Impax Laboratories of propping up its stock price with false and misleading statements.

U.S. District Judge Haywood Gilliam Jr. on Sept. 3 gave the plaintiffs 21 days to amend but "cautions plaintiffs that it will consider only factual, rather than conclusory, allegations when assessing the viability of any amended complaint."

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Email *

Submit